In the fight against cancer, the best weapon might be the enemy’s own communication system. In 2026, the Exosome Therapeutics Market is heavily dominated by oncology, with over 40% of all current research efforts dedicated to "Anti-Cancer" applications. Scientists are learning how to "Hijack" the way cancer cells send messages to one another, replacing those harmful signals with...